1. Home
  2. RCEL vs AGD Comparison

RCEL vs AGD Comparison

Compare RCEL & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • AGD
  • Stock Information
  • Founded
  • RCEL 2020
  • AGD 2006
  • Country
  • RCEL United States
  • AGD United Kingdom
  • Employees
  • RCEL N/A
  • AGD N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • AGD Trusts Except Educational Religious and Charitable
  • Sector
  • RCEL Health Care
  • AGD Finance
  • Exchange
  • RCEL Nasdaq
  • AGD Nasdaq
  • Market Cap
  • RCEL 310.6M
  • AGD 253.4M
  • IPO Year
  • RCEL N/A
  • AGD N/A
  • Fundamental
  • Price
  • RCEL $12.87
  • AGD $10.03
  • Analyst Decision
  • RCEL Hold
  • AGD
  • Analyst Count
  • RCEL 3
  • AGD 0
  • Target Price
  • RCEL $16.50
  • AGD N/A
  • AVG Volume (30 Days)
  • RCEL 112.9K
  • AGD 61.2K
  • Earning Date
  • RCEL 11-07-2024
  • AGD 01-01-0001
  • Dividend Yield
  • RCEL N/A
  • AGD 8.13%
  • EPS Growth
  • RCEL N/A
  • AGD N/A
  • EPS
  • RCEL N/A
  • AGD N/A
  • Revenue
  • RCEL $60,040,000.00
  • AGD N/A
  • Revenue This Year
  • RCEL $34.73
  • AGD N/A
  • Revenue Next Year
  • RCEL $54.61
  • AGD N/A
  • P/E Ratio
  • RCEL N/A
  • AGD N/A
  • Revenue Growth
  • RCEL 32.24
  • AGD N/A
  • 52 Week Low
  • RCEL $7.51
  • AGD $8.20
  • 52 Week High
  • RCEL $18.93
  • AGD $9.78
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 64.34
  • AGD 35.07
  • Support Level
  • RCEL $11.63
  • AGD $10.30
  • Resistance Level
  • RCEL $13.82
  • AGD $10.23
  • Average True Range (ATR)
  • RCEL 0.86
  • AGD 0.10
  • MACD
  • RCEL 0.09
  • AGD -0.02
  • Stochastic Oscillator
  • RCEL 74.46
  • AGD 5.95

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.

Share on Social Networks: